Page 2 - Gel Technologies News Today

Aerovate Therapeutics (NASDAQ:AVTE – Get Free Report) and Sol-Gel Technologies (NASDAQ:SLGL – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation. Volatility & Risk Aerovate Therapeutics has a […]

Event to be held on December 6, 2023 will focus on preventing basal cell carcinomas associated with Gorlin syndrome with a discussion of the disease...

Event to be held on December 6, 2023 will focus on preventing basal cell carcinomas associated with Gorlin syndrome with a discussion of the disease burden, SGT-610 and the upcoming Phase 3 trial NESS ZIONA, Israel, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (Nasdaq: SLGL) (“Sol-Gel”), a dermatology company leveraging innovative approaches to develop pioneering treatments for patients with severe skin conditions, and with two approved large-category dermatology pr...

Sol-Gel Technologies Ltd. (NASDAQ:SLGL – Get Free Report) saw a significant increase in short interest in the month of October. As of October 15th, there was short interest totalling 59,200 shares, an increase of 16.5% from the September 30th total of 50,800 shares. Based on an average daily volume of 10,400 shares, the short-interest ratio […]

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Leading biotech company Assembly Biosciences has recently announced the selection of ABI-6250 as a promising candidate for the treatment of chronic hepatitis

Sol-Gel Technologies Ltd. (NASDAQ:SLGL – Free Report) – HC Wainwright lifted their Q3 2023 earnings per share (EPS) estimates for shares of Sol-Gel Technologies in a report released on Monday, August 14th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings of ($0.24) per share for the quarter, up from their […]

Sol-Gel Technologies (NASDAQ:SLGL – Free Report) had its target price lowered by Raymond James from $9.00 to $7.00 in a research note released on Friday morning, Marketbeat Ratings reports. The firm currently has a strong-buy rating on the stock. Separately, HC Wainwright restated a buy rating and set a $19.00 price objective on shares of […]

Sol-Gel Technologies (NASDAQ:SLGL – Free Report) had its target price decreased by Raymond James from $10.00 to $9.00 in a report released on Wednesday morning, FlyOnTheWall reports. Separately, HC Wainwright reaffirmed a buy rating and set a $19.00 target price on shares of Sol-Gel Technologies in a research report on Wednesday, April 12th. Sol-Gel Technologies […]

Key Insights Sol-Gel Technologies' significant insider ownership suggests inherent interests in company's expansion...